SLC9A3R1

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA009672

Antibody HPA027247

Antibody CAB001962

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Distinct membranous and cytoplasmic staining was observed in fractions of cases in most adenocarcinomas. Malignant cells in general were weakly stained or negative.Moderate to strong cytoplasmic positivity was observed in breast cancers while several cases of endometrial, ovaria renal and embryonal carcinomas of testis displayed strong luminal membrane staining. Nuclear positivity was occasionally observed in liver, lung, breast and renal cancers. Remaining malignancies were mainly negative.Most malignancies showed strong cytoplasmic positivity with additional membranous immunoreactivity. Hepatocellular cancer were mainly negative.

Validation

Uncertain: Two (or more) antibodies yielding partly similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data
Supportive: Two (or more) antibodies yielding similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data
Uncertain: Two (or more) antibodies yielding partly similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected